Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Markku Jalkanen Insider Profile
25 Followers
Markku Jalkanen, Director at Faron Pharmaceuticals Oy, holds 3.41M shares in Faron Pharmaceuticals Oy (Ticker: GB:FARN).
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+131.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Markku Jalkanen's holdings
Insider Roles
Director
Roles that Markku Jalkanen holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 28, 2019 - Mar 28, 2020
Return:+646.00%
The most profitable trade made by Markku Jalkanen
Markku Jalkanen's Trading History
List of latest transactions for each holding click on a transaction to see Markku Jalkanen's performance on stock
You May Also Like
Markku Jalkanen insider profile FAQ
What is the percentage of profitable transactions made by Markku Jalkanen?
The percentage of profitable transactions made by Markku Jalkanen is 83%.
What is the average return per transaction made by Markku Jalkanen?
The average return per transaction made by Markku Jalkanen is 131.50%.
What stocks does Markku Jalkanen hold?
Markku Jalkanen holds: GB:FARN stocks.
What was Markku Jalkanen’s latest transaction?
Markku Jalkanen latest transaction was an Uninformative Buy of ―.
What was Markku Jalkanen's most profitable transaction?
Markku Jalkanen’s most profitable transaction was an Informative Buy of GB:FARN stock on March 28, 2019. The return on the trade was 646.00%.
What is Markku Jalkanen's role in Faron Pharmaceuticals Oy?
Markku Jalkanen's role in Faron Pharmaceuticals Oy is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.